pressed for live cell studies, and enabled detailed kinetic analysis of rapid cellular processes. The biosensor revealed Cdc42 activation in the trans-Golgi compartment, microtubule-dependent activation at the cell periphery but not in filopodia, and tightly coordinated kinetics of cell extension, retraction, and Cdc42 activation.
Advanced Cardiac Morphogenesis Does Not Require Heart Tube Fusion
The bilateral cardiac mesoderm migrates from the lateral region of the embryo to the ventral midline, where it fuses to form the primitive heart tube. It is generally accepted that migration and fusion are essential for subsequent stages of cardiac morphogenesis. We present evidence that, in Foxp4 mutant embryonic mice, each bilateral heart-forming region is capable of developing into a highly differentiated four-chambered mammalian heart in the absence of midline fusion. These data demonstrate that left-right chamber specification, cardiac looping, septation, cardiac myocyte differentiation, and endocardial cushion formation are preprogrammed in the precardiac mesoderm and do not require midline positional identity or heart tube fusion.
Although the molecular mechanisms underlying cardiac myocyte differentiation have been extensively examined and initial molecular pathways have been identified, much less is understood about how specified myocardial cells form the primitive heart tube and the four-chambered mammalian heart. This complex morphological process has a major impact on human health, because cardiovascular defects account for a substantial percentage of neonatal congenital disease. The bilateral precardiac mesoderm forms at the anterior pole of the vertebrate embryo (1, 2) . How this mesoderm migrates to the ventral midline to form the single heart tube in the embryo is not well understood, although contributions from anterior foregut endoderm have been implicated. Moreover, whether this fusion event is required for cardiac differentiation and morphogenesis is not known, although some markers of the cardiac myocyte lineage that become spatially restricted in later development (such as eHAND, MLC2a, and MLC2v) are expressed throughout the early precardiac mesoderm (1, 2) . The heart is also the first organ to exhibit left-right asymmetry. Whether this asymmetry is preprogrammed into the precardiac mesoderm or whether it is acquired coincident with midline fusion is unknown. Most genetic models of defective heart tube fusion, also known as cardia bifida, are characterized by bilateral regions of specified cardiac mesoderm that express cardiac-specific genes but fail to progress through later stages of cardiac morphogenesis (3) (4) (5) . In addition, most murine models of cardia bifida exhibit additional extracardiac defects in body pattern formation, including severe defects in ventral morphogenesis and embryonic turning (3, 6) . These data have led to a working model in which ventral midline fusion of the bilateral cardiac primordia is essential for subsequent cardiac development and morphogenesis, especially later aspects of chamber identity, left-right cardiac asymmetry, and looping morphogenesis (1, 7) . We have previously cloned and characterized Foxp4, a member of the Fox gene family that is expressed in multiple tissues, including the lung, gut, and brain, in the developing mouse embryo (8, 9) . Foxp4 is expressed in early foregut endoderm and later in development in lung and hindgut (8) S1C ). Heterozygous embryos were fertile and exhibited no obvious defects (10) . The majority of homozygous embryos died around embryonic day 12.5 (E12.5) (table S1).
Histological analysis from E8.5 to E12.5 revealed the development of two complete hearts in Foxp4 mutant embryos (Fig. 1B) . This was apparent as early as E8.5, when midline fusion of the bilateral cardiac primordia has normally occurred (Fig. 1, C and D) . The two hearts in Foxp4 mutants were positioned bilaterally, suggesting a lack of proper migration of the precardiac primordia to the midline (Fig. 1 , C to H). Foxp4 mutants exhibited grossly normal ventral morphogenesis and embryonic turning (Fig. 1, A to H) , suggesting that cardia bifida was not due to secondary defects in these processes, as has been observed in other mouse models (3) (4) (5) (6) 11) . Upon sacrifice (E8.5 to E12.5), each of the two bilateral hearts was beating at approximately the same rate as in wild-type embryos, although they were asynchronous (10).
Hematoxylin and eosin (HϩE) staining showed that each heart in Foxp4 mutants had distinct atria and ventricles (Fig. 1, I and J). Proper chamber septation and left-right chamber specification was evident from the expression of eHAND and dHAND (Fig. 1, J and K). Endocardial cushions were also present (Fig. 1L) . In both wild-type and Foxp4 mutant hearts, MLC2a and MLC2v were expressed in the atria and ventricles, respectively (Fig. 2, A to D) , while plexin D1 was expressed in the developing endocardium ( Fig. 2E) (12, 13) . These data support the conclusion that bilateral heart tube fusion is not required for cell or chamber specification in the heart. Furthermore, the position of the atria dorsal and cranial to the ventricles suggests that looping morphogenesis occurs in the bilateral hearts of Foxp4 mutants despite the absence of midline fusion (Fig. 2 
, B and D).
A hallmark of ventricular myocyte differentiation and maturation is the generation of compact and trabecular myocardium. Compact myocardium lies in the outer region of the ventricular wall and is more proliferative and less mature than trabecular myocardium (14) . Development of distinct trabecular and compact myocardium is thought to enhance contractility and compartmentalization of oxygenated and unoxygenated blood before septation (14 ) . The formation of trabecular myocardium is essential for cardiac function as demonstrated in neuregulin knockout mice that lack trabecular myocardium and die at E10.5 because of heart failure (15 ). Compact myocardium can be distinguished by expression of N-myc, whereas trabecular myocardium can be distinguished by expression of atrial naturetic factor (ANF) (16 ) . To determine whether proper development of compact and trabecular myocardium occurred in Foxp4 mutant hearts, we performed in situ hybridizations to assess N-myc and ANF expression. N-myc and ANF were expressed in Foxp4 mutant hearts in the same pattern as in wild-type hearts, with expression of N-myc observed in compact myocardium and ANF expression observed in trabecular myocardium (Fig. 2 , F and G) (15, 16 ) . Taken together, these data demonstrate that Foxp4 mutants develop two hearts with proper chamber formation and normal trabecular and compact myocardial development.
The heart is the first organ to display asymmetry during development (17, 18) . Along with other lateral-plate mesoderm derivatives, the heart expresses Pitx2, a bicoid-related homeodomain transcription factor, only on its left side; Pitx2 mutants exhibit multiple embryonic defects, including defective cardiac positioning after looping (19) . At E10.5, Foxp4 mutants have two visible hearts that were positioned bilateral to the ventral midline (Fig. 3, A to D) . Pitx2 expression was observed in the left heart of Foxp4 mutant embryos, whereas expression was not observed in the right heart (Fig. 3E) . These data suggest that embryonic left-right asymmetry was retained in Foxp4 mutants. To determine whether cardiac specific left-right asymmetry was retained in Foxp4 mutant hearts, we performed in situ hybridization to determine expression of the basic helix-loop-helix (bHLH) transcription factors eHAND and dHAND and of FGF10, a member of the fibroblast growth factor family. eHAND is normally expressed primarily in the left side of the developing heart, whereas dHAND and FGF10 are expressed primarily on the right side of the developing heart (20, 21) . We observed eHAND expression in the (Fig. 3, F and  G, and fig. S2 ). These data demonstrate that development of cardiac left-right asymmetry does not require heart tube fusion and that embryonic and cardiac asymmetry are specified by distinct mechanisms. These data demand a reconsideration of the currently accepted models of cardiac development and morphogenesis to accommodate the observation that precardiac mesoderm is capable of left-right asymmetrical chamber development, looping, myocyte differentiation, and endocardial cushion formation in the absence of midline heart tube fusion.
Our previous studies have shown that Foxp4 mRNA expression in the heart at E10.5 cannot be demonstrated by in situ hybridization, although it can be demonstrated in the adult heart by Northern blot analysis (8) . However, abundant levels of Foxp4 protein expression in the embryo are observed in the anterior foregut endoderm ( fig. S3F ). Immunohistochemistry shows that Foxp4 protein expression is not observed in cardiac myocytes at E9.5 to E14.5 ( fig. S2 , A to C). In contrast, expression is observed in the epicardium and endocardium at these times ( fig. S3, A to C) .
Histological analysis identified defects in anterior foregut endoderm development in Foxp4 mutants. As shown in Fig. 1D , at E8.5, the anterior foregut was open in mutant embryos, whereas in wild-type embryos it was a closed tube. At E10.5, the most anterior aspects of the foregut remained open in Foxp4 mutants, whereas more posterior regions were closed (Fig. 4 , A to C). By E11.5, the foregut had closed in Foxp4 mutants in the anterior region, but failed to separate into the esophagus and trachea; however, it did give rise to endodermally derived tissues, including the lung and liver (Fig. 4, D to I) . At E11.5, terminal deoxynucleotidyl transferasemediated deoxyuridine triphosphate nick end labeling assays revealed that anterior endoderm was highly apoptotic (fig. S4, A and B) , and by E12.5, this region of the foregut had degraded, leaving a large open cavity in the embryo (Fig. 4 , J to O). However, foregut endoderm was properly specified as demonstrated by expression of sonic hedgehog (SHH) and Foxa2 ( fig. S4 , C to H) (10) . Together, these data suggest that Foxp4 mutants exhibit a delay in anterior foregut closure and cell death-mediated loss of anterior foregut endoderm after closure. We hypothesize that the defects in anterior foregut development may be responsible for cardia bifida in Foxp4 mutants. Although these defects led to a delay in foregut closure in Foxp4 mutants, the neural tube, limb buds, and head structures formed normally, indicating that the vast majority of ventral morphogenetic processes were unperturbed (Figs. 1 to 3) .
Defects in anterior foregut endoderm development have previously been associated with cardia bifida. Mutations in several zebrafish genes expressed in the foregut endoderm, including casanova (sox32) and faust (GATA5), result in cardia bifida, and these mutants display severe defects or complete lack of foregut endoderm development (22, 23) . In mice lacking GATA4, anterior foregut endoderm development is defective, and GATA4-null embryos display cardia bifida (3, 4) . Thus, the correlation between foregut defects and cardia bifida phenotypes is very strong. However, there are distinct differences between these mutants and Foxp4 mutants. GATA4 mutants have severe defects in ventral morphogenesis and lack proper cardiac chamber development (3, 4) . Moreover, zebrafish cardiac morphogenesis is distinctly different from that in mammals, in that there are only two chambers and the heart does not loop or septate, but instead forms a serial connection between the single atria and ventricle. Although other models of cardia bifida have been reported, including Mesp1 and furin mutant mice, these embryos either die too early to examine the complex morphogenetic processes required for late-stage cardiac development or they exhibit other severe defects in general developmental processes such as embryonic turning (5, 6, 11) . Thus, none of the cardia bifida mutants described previously has permitted the analysis of complex cardiac development in sufficient detail to determine whether the later stages of cardiac morphogenesis require heart tube fusion.
Foxp4 mutant embryos demonstrate that bilateral heart tube migration and fusion are not required for extensive cardiac development, including chamber formation, ventricular myocyte differentiation, looping, endocardial cushion formation, and development of cardiac left-right asymmetry. These data indicate a higher degree of preprogramming in the bilateral precardiac mesoderm than has been appreciated and indicate that a redefinition of the current model of cardiac development is required (1). Fig.  1A . The death of the majority of the population takes place as a fast exponential decay characterized by a single parameter, the killing rate. After a few hours, the initial purely exponential decay of the killing curve changes to a more complex, slowly decreasing function. By the time the antibiotic is removed, a small fraction of the cells still survives. These cells have not genetically acquired antibiotic resistance: They regrow a new population that is as sensitive to the antibiotic. This phenomenon, termed bacterial persistence, was first reported for staphylococcal infections treated with penicillin (1) and has since been observed in many bacterial species. Despite being observed almost 60 years ago, the mechanism behind persistence remains a puzzle (2) . It has been suggested that persistent bacteria are in some protected part of the cell cycle at the time of exposure to antibiotics or are able to adapt rapidly to the antibiotic stress (3). It has also been proposed that those cells are in a dormant state or are unable to initiate programmed cell death (2, 4) . To clarify the nature of persistence, it is crucial to know whether persistent bacteria differ from others before exposure to antibiotics and, if so, what triggers such phenotypic differentiation. To answer these questions quantitatively, we investigated the persistence of E. coli at the level of single cells by direct observation and measurement with the use of optical microscopy. Such measurements were made possible by the use of previously isolated high persistence (hip) mutants of E. coli that have an increased proportion of persisters (5, 6) and by the recent development of transparent microfluidic devices (7, 8) .
We designed and fabricated microfluidic devices by using the techniques of soft lithography (9, 10) to pattern layers of poly (dimethylsiloxane) (PDMS) (Fig. 1B) 
